Twenty Years of Quiescence after Nonstop Remicade® (Infliximab) Infusions in a Child with Ocular Behçet Disease Presenting as Hypopyon-Anterior Uveitis Refractory to Immunosuppressants
I report a case with ocular Behçet disease presenting as hypopyon-anterior uveitis refractory to conventional immunosuppressive drugs who was safely and effectively managed for 20 years by nonstop infusions of a modern anti-TNF agent, infliximab. A 14-year-old girl who had a history of recurrent oro...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-02-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/528593 |